Telomere Therapeutics

telomere-tx.com ↗ ·Madrid ·Seed

Telomere Therapeutics is a Spanish gene therapy company developing AAV-based telomerase (TERT) therapies to repair telomeres and treat organ fibrosis and telomere-dysfunction syndromes, with a lead program in idiopathic pulmonary fibrosis and further programs in renal fibrosis, aplastic anemia and dyskeratosis congenita. Founded in 2020 as a spin-off of Spain's National Cancer Research Centre (CNIO) and the Universitat Autònoma de Barcelona (UAB/CBATEG), it is based at the Parque Científico de Madrid and is at preclinical/IND-enabling stage. It is backed by Invivo Ventures plus public co-investment (CDTI Innvierte) and grants including a ~€2.3M EIC Accelerator award.

Founded

2020

Founders

Total funds raised

€3.4M

SectorsBiotech, Gene Therapy, Pharmaceuticals, Longevity & Aging, Life Sciences Start-up MapHealthtech & Bio › Drug discovery & therapeutics developers

Suggest a correction

Founders

Fàtima Bosch i Tubert

Co-founder (Scientific Founder); Director of CBATEG, Universitat Autònoma de Barcelona

María A. Blasco

Co-founder (Scientific Founder); Head of the Telomeres and Telomerase Group, CNIO

Paula Martínez

Co-founder (Scientific Founder); Researcher, Telomeres and Telomerase Group, CNIO

Global models 4

Life Biosciences

United States · www.lifebiosciences.com ↗

Preclinical-to-clinical biotech that uses AAV-delivered gene therapy to reverse cellular ageing in age-related diseases, aiming to license or partner its programmes.

$200MComparable